Cargando…

HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report

BACKGROUND: Cases of subacute thyroiditis (SAT) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. A human leukocyte antigen (HLA) allele, HLA-B*35, appears to be involved in the pathogenesis of SAT. CASE PRESENTATION: We conducted HLA typing of one pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Shigemitsu, Suzuki, Seiya, Yanagisawa, Shinnosuke, Morita, Hideo, Haisa, Akifumi, Satomura, Atsushi, Nakajima, Ritsuko, Oikawa, Yoichi, Inoue, Ikuo, Shimada, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988595/
https://www.ncbi.nlm.nih.gov/pubmed/36879263
http://dx.doi.org/10.1186/s12902-023-01287-5
_version_ 1784901602646163456
author Yasuda, Shigemitsu
Suzuki, Seiya
Yanagisawa, Shinnosuke
Morita, Hideo
Haisa, Akifumi
Satomura, Atsushi
Nakajima, Ritsuko
Oikawa, Yoichi
Inoue, Ikuo
Shimada, Akira
author_facet Yasuda, Shigemitsu
Suzuki, Seiya
Yanagisawa, Shinnosuke
Morita, Hideo
Haisa, Akifumi
Satomura, Atsushi
Nakajima, Ritsuko
Oikawa, Yoichi
Inoue, Ikuo
Shimada, Akira
author_sort Yasuda, Shigemitsu
collection PubMed
description BACKGROUND: Cases of subacute thyroiditis (SAT) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. A human leukocyte antigen (HLA) allele, HLA-B*35, appears to be involved in the pathogenesis of SAT. CASE PRESENTATION: We conducted HLA typing of one patient with SAT and another with both SAT and Graves’ disease (GD), which developed after SARS-CoV-2 vaccination. Patient 1, a 58-year-old Japanese man, was inoculated with a SARS-CoV-2 vaccine (BNT162b2; Pfizer, New York, NY, USA). He developed fever (38 °C), cervical pain, palpitations, and fatigue on day 10 after vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum C-reactive protein (CRP) and slightly increased serum antithyroid-stimulating antibody (TSAb) levels. Thyroid ultrasonography revealed the characteristic findings of SAT. Patient 2, a 36-year-old Japanese woman, was inoculated twice with a SARS-CoV-2 vaccine (mRNA-1273; Moderna, Cambridge, MA, USA). She developed fever (37.8 °C) and thyroid gland pain on day 3 after the second vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum CRP, TSAb, and antithyroid-stimulating hormone receptor antibody levels. Fever and thyroid gland pain persisted. Thyroid ultrasonography revealed the characteristic findings of SAT (i.e., slight swelling and a focal hypoechoic area with decreased blood flow). Prednisolone treatment was effective for SAT. However, thyrotoxicosis causing palpitations relapsed thereafter, for which thyroid scintigraphy with (99m)technetium pertechnetate was conducted, and the patient was diagnosed with GD. Thiamazole treatment was then initiated, which led to improvement in symptoms. CONCLUSION: HLA typing revealed that both patients had the HLA-B*35:01, -C*04:01, and -DPB1*05:01 alleles. Only patient 2 had the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles. The HLA-B*35:01 and HLA-C*04:01 alleles appeared to be involved in the pathogenesis of SAT after SARS-CoV-2 vaccination, and the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles were speculated to be involved in the postvaccination pathogenesis of GD.
format Online
Article
Text
id pubmed-9988595
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99885952023-03-07 HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report Yasuda, Shigemitsu Suzuki, Seiya Yanagisawa, Shinnosuke Morita, Hideo Haisa, Akifumi Satomura, Atsushi Nakajima, Ritsuko Oikawa, Yoichi Inoue, Ikuo Shimada, Akira BMC Endocr Disord Case Report BACKGROUND: Cases of subacute thyroiditis (SAT) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. A human leukocyte antigen (HLA) allele, HLA-B*35, appears to be involved in the pathogenesis of SAT. CASE PRESENTATION: We conducted HLA typing of one patient with SAT and another with both SAT and Graves’ disease (GD), which developed after SARS-CoV-2 vaccination. Patient 1, a 58-year-old Japanese man, was inoculated with a SARS-CoV-2 vaccine (BNT162b2; Pfizer, New York, NY, USA). He developed fever (38 °C), cervical pain, palpitations, and fatigue on day 10 after vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum C-reactive protein (CRP) and slightly increased serum antithyroid-stimulating antibody (TSAb) levels. Thyroid ultrasonography revealed the characteristic findings of SAT. Patient 2, a 36-year-old Japanese woman, was inoculated twice with a SARS-CoV-2 vaccine (mRNA-1273; Moderna, Cambridge, MA, USA). She developed fever (37.8 °C) and thyroid gland pain on day 3 after the second vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum CRP, TSAb, and antithyroid-stimulating hormone receptor antibody levels. Fever and thyroid gland pain persisted. Thyroid ultrasonography revealed the characteristic findings of SAT (i.e., slight swelling and a focal hypoechoic area with decreased blood flow). Prednisolone treatment was effective for SAT. However, thyrotoxicosis causing palpitations relapsed thereafter, for which thyroid scintigraphy with (99m)technetium pertechnetate was conducted, and the patient was diagnosed with GD. Thiamazole treatment was then initiated, which led to improvement in symptoms. CONCLUSION: HLA typing revealed that both patients had the HLA-B*35:01, -C*04:01, and -DPB1*05:01 alleles. Only patient 2 had the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles. The HLA-B*35:01 and HLA-C*04:01 alleles appeared to be involved in the pathogenesis of SAT after SARS-CoV-2 vaccination, and the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles were speculated to be involved in the postvaccination pathogenesis of GD. BioMed Central 2023-03-07 /pmc/articles/PMC9988595/ /pubmed/36879263 http://dx.doi.org/10.1186/s12902-023-01287-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Yasuda, Shigemitsu
Suzuki, Seiya
Yanagisawa, Shinnosuke
Morita, Hideo
Haisa, Akifumi
Satomura, Atsushi
Nakajima, Ritsuko
Oikawa, Yoichi
Inoue, Ikuo
Shimada, Akira
HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title_full HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title_fullStr HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title_full_unstemmed HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title_short HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
title_sort hla typing of patients who developed subacute thyroiditis and graves’ disease after sars-cov-2 vaccination: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988595/
https://www.ncbi.nlm.nih.gov/pubmed/36879263
http://dx.doi.org/10.1186/s12902-023-01287-5
work_keys_str_mv AT yasudashigemitsu hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT suzukiseiya hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT yanagisawashinnosuke hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT moritahideo hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT haisaakifumi hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT satomuraatsushi hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT nakajimaritsuko hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT oikawayoichi hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT inoueikuo hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport
AT shimadaakira hlatypingofpatientswhodevelopedsubacutethyroiditisandgravesdiseaseaftersarscov2vaccinationacasereport